Article
M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome
16 Nov 2020
Abstract excerpt
Background: Breast cancer heterogeneity is an essential element that plays a role in the therapy response variability and the patient's outcome. This highlights the need for more precise subtyping methods that focus not only on tumor cells but also investigate the profile of stromal cells as well as immune cells. Objectives: To mine publicly available transcriptomic breast cancer datasets and reanalyze their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
